Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.18%142.35B | -0.63%574.95B | 0.11%142.09B | -0.08%578.56B | -2.83%140.2B | -1.14%151.13B | 0.78%145.3B | 3.09%141.94B | 9.32%579.01B | 3.68%144.29B |
| Cost of revenue | 1.48%117.66B | -2.05%470.76B | -3.16%115.95B | 0.96%480.62B | -1.58%118.35B | -1.67%122.81B | 1.97%119.73B | 5.49%119.73B | 8.80%476.06B | 3.24%120.24B |
| Gross profit | -5.57%24.69B | 6.37%104.19B | 17.73%26.14B | -4.86%97.95B | -9.11%21.86B | 1.25%28.32B | -4.43%25.57B | -8.18%22.21B | 11.77%102.95B | 5.91%24.05B |
| Operating expense | -0.30%16.03B | 16.31%64.78B | 13.00%16.08B | 5.24%55.7B | 8.40%12.66B | -4.26%12.96B | 15.56%15.85B | 1.67%14.23B | -4.00%52.92B | -20.22%11.68B |
| Selling and administrative expenses | 6.69%15.85B | 3.83%61.34B | --14.86B | 11.10%59.07B | ---- | ---- | ---- | ---- | --53.17B | ---- |
| -General and administrative expense | 6.69%15.85B | 3.83%61.34B | --14.86B | 11.10%59.07B | ---- | ---- | ---- | ---- | --53.17B | ---- |
| Other operating expenses | -91.07%180M | -9.98%4.45B | --2.02B | 265.85%4.94B | ---- | ---- | ---- | ---- | --1.35B | ---- |
| Total other operating income | --0 | -87.95%1B | --794M | 419.81%8.32B | ---- | ---- | ---- | ---- | --1.6B | ---- |
| Operating profit | -13.99%8.66B | -6.73%39.41B | 26.17%10.07B | -15.54%42.25B | -25.64%9.2B | 6.42%15.36B | -25.46%9.72B | -21.70%7.98B | 35.27%50.03B | 53.32%12.37B |
| Net non-operating interest income (expenses) | -23.82%921M | 4.65%2.03B | 652.05%1.21B | 12.62%1.94B | 11.55%2.52B | -728.88%-1.55B | 697.98%1.18B | -40.38%-219M | 352.05%1.72B | 1,341.76%2.26B |
| Non-operating interest income | -21.60%1.13B | 1.47%3.11B | 2,222.58%1.44B | 13.16%3.07B | 8.92%2.81B | -2,494.44%-1.29B | 3,215.56%1.49B | 77.14%62M | 1,823.40%2.71B | 7,061.11%2.58B |
| Non-operating interest expense | -9.96%208M | -3.97%1.09B | -17.79%231M | 14.10%1.13B | -9.75%287M | 6.64%257M | 26.75%308M | 47.12%281M | 20.66%993M | 45.87%318M |
| Net investment income | 53.95%1.78B | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -3.40%142M | 38.14%1.22B | -24.23%147M | 8.50%881M | -8.93%408M | 175.86%160M | 23.96%119M | -7.62%194M | 30.76%812M | 318.69%448M |
| Special income (charges) | 86.05%-12M | |||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -86.05%12M | ---- | ---- |
| Other non-operating income (expenses) | -183.87%-26M | |||||||||
| Income before tax | -14.91%9.72B | -5.36%42.65B | 17.89%11.43B | -14.25%45.07B | -6.43%13.03B | -12.58%13.07B | -24.82%9.28B | -14.53%9.69B | 28.99%52.56B | 102.80%13.92B |
| Income tax | -30.04%2.8B | -3.21%12.09B | 39.03%4B | -10.64%12.49B | -47.71%2.73B | -20.91%3.58B | -6.92%3.3B | 322.29%2.88B | 25.73%13.98B | 212.62%5.23B |
| Net income | -6.74%6.92B | -6.18%30.56B | 8.96%7.42B | -15.56%32.57B | 18.38%10.29B | -8.96%9.49B | -32.02%5.98B | -36.10%6.81B | 30.21%38.58B | 67.46%8.7B |
| Net income continuous operations | -6.74%6.92B | -6.18%30.56B | 8.94%7.42B | -15.56%32.57B | 18.38%10.29B | -8.95%9.49B | -32.04%5.98B | -36.09%6.81B | 30.21%38.58B | 67.44%8.7B |
| Noncontrolling interests | -21.89%503M | 11.24%2.25B | 30.10%644M | -11.21%2.02B | -17.90%477M | -4.17%505M | 48.09%542M | -38.13%495M | -16.70%2.27B | 15.97%581M |
| Net income attributable to the company | -5.31%6.42B | -7.33%28.31B | 7.30%6.78B | -15.83%30.56B | 20.97%9.82B | -9.21%8.98B | -35.50%5.44B | -35.93%6.32B | 34.98%36.3B | 72.99%8.12B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -5.31%6.42B | -7.33%28.31B | 7.30%6.78B | -15.83%30.56B | 20.97%9.82B | -9.21%8.98B | -35.50%5.44B | -35.93%6.32B | 34.98%36.3B | 72.99%8.12B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -1.95%31.18 | -6.14%134.57 | 7.31%31.8 | -15.82%143.37 | 20.99%46.06 | -9.21%42.14 | -35.49%25.536 | -35.93%29.634 | 34.97%170.32 | 72.94%38.07 |
| Diluted earnings per share | -1.95%31.16 | -6.15%134.53 | 7.24%31.78 | -15.83%143.35 | 20.99%46.06 | -9.21%42.1398 | -35.49%25.5339 | -35.93%29.634 | 34.97%170.32 | 72.97%38.07 |
| Dividend per share | 0 | 2.17%47 | 0 | 0.00%46 | 0.00%26 | 0 | 0.00%20 | 0 | 27.78%46 | 30.00%26 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |